The Drummond Report is attracting significant attention with its somewhat dire outlook for the Ontario economy. The report includes a notable warning about the costs of the proposed Canada – EU Trade Agreement, particularly the increased costs arising from patent reforms being promoted by large pharmaceutical companies: The outcome of […]
Post Tagged with: "pharma"
Report Says Canada – EU Trade Deal Could Cost Ontario $1.2 Billion Per Year From Higher Pharma Costs
The Globe’s Jeffrey Simpson has an excellent column on the state of big pharma in Canada, noting that Canadians pay high prices for pharmaceuticals but that big pharma has not met its commitment to devote 10 percent of sales to research and development. Prices would increase further with potential legal […]
Dr. Marc-AndrÃ© Gagnon, an assistant professor with the School of Public Policy and Administration at Carleton University and Dr. Sergio Sismondo, professor of Philosophy and Sociology at Queen’s University, write an op-ed about the growing problem of big pharmaceutical companies ghost writing opinion pieces in support of their drugs.